| 1 | [SID49648784] | Active | CC50 | 0.039 | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds [AID1650, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | CC50 | 0.039 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds | | AID | 1650 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49648784] | Active | IC50 | 0.05 | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | IC50 | 0.05 [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49648784] | Active | CC50 | 0.1 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | CC50 | 0.1 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49648784] | Active | Potency | 0.1032 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1032 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49648784] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 6 | [SID49648784] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 7 | [SID49648784] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 8 | [SID49648784] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 9 | [SID49648784] | Active | Potency | 0.1836 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 0.1836 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 10 | [SID49648784] | Active | Potency | 1 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID49648784] | Active | EC50 | 1.013 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast [AID1933, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | 1.013 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast | | AID | 1933 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID49648784] | Active | Potency | 1.0323 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID49648784] | Active | EC50 | 1.138 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast [AID1934, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | 1.138 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast | | AID | 1934 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID49648784] | Active | Potency | 1.8356 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 1.8356 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID49648784] | Active | Potency | 1.9953 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID49648784] | Active | Potency | 1.9953 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 17 | [SID49648784] | Active | Potency | 15.8489 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 18 | [SID49648784] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD1 [AID1578, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD1 | | AID | 1578 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 19 | [SID49648784] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD1 [AID1578, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD1 | | AID | 1578 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 20 | [SID49648784] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 21 | [SID49648784] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 22 | [SID49648784] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 23 | [SID49648784] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 24 | [SID49648784] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 25 | [SID49648784] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 26 | [SID49648784] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 27 | [SID49648784] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 28 | [SID49648784] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 29 | [SID49648784] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 30 | [SID49648784] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 31 | [SID49648784] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 32 | [SID49648784] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID651615, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 651615 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 33 | [SID49648784] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). [AID588824, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). | | AID | 588824 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 34 | [SID49648784] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID588794, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 588794 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 35 | [SID49648784] | Active | | | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity [AID504558, Type: screening] | LMP1 [Human herpesvirus 4] [gi:23893668] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504558 | | BioAssay type | screening | | Target | LMP1 [Human herpesvirus 4] [gi:23893668] | | PubMed | | | Data Table |  |
|
| 36 | [SID49648784] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 37 | [SID49648784] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 38 | [SID49648784] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 39 | [SID49648784] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 40 | [SID49648784] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 41 | [SID49648784] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 42 | [SID49648784] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 43 | [SID49648784] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 44 | [SID49648784] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 45 | [SID49648784] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 46 | [SID49648784] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 47 | [SID49648784] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 48 | [SID49648784] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 49 | [SID49648784] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 50 | [SID49648784] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_1, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49648784 | | CID | 16403454 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|